Study on Development and Countermeasure of Medical Circulation Industry in China under New Healthcare Reform Background

摘要

Based on the status quo and characteristics of pharmaceutical circulation industry in China under the background of new healthcare reform, this article does a profound research about the development countermeasure of pharmaceutical circulation industry for further development, and points out that China has to establish a unified industry standards and a national distribution system to develop modern pharmaceutical logistics. It sets up a province-city secondary distribution system, through comparing it with the other two distribution mode, drawing a conclusion that the secondary distribution system is feasible. Besides, the paper holds that large pharmaceutical wholesale enterprises should increase their level of information and small and medium-sized enterprises rapidly transition to develop third-party logistics (hereinafter short for 3PL) in the next round of competition, which possesses guiding significance for medical circulation enterprises to make plans.